232 related articles for article (PubMed ID: 27165780)
1. Gain-of-function mutations in protein kinase Cα (PKCα) may promote synaptic defects in Alzheimer's disease.
Alfonso SI; Callender JA; Hooli B; Antal CE; Mullin K; Sherman MA; Lesné SE; Leitges M; Newton AC; Tanzi RE; Malinow R
Sci Signal; 2016 May; 9(427):ra47. PubMed ID: 27165780
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase Cα gain-of-function variant in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation.
Callender JA; Yang Y; Lordén G; Stephenson NL; Jones AC; Brognard J; Newton AC
Proc Natl Acad Sci U S A; 2018 Jun; 115(24):E5497-E5505. PubMed ID: 29844158
[TBL] [Abstract][Full Text] [Related]
3. Enhanced activity of Alzheimer disease-associated variant of protein kinase Cα drives cognitive decline in a mouse model.
Lordén G; Wozniak JM; Doré K; Dozier LE; Cates-Gatto C; Patrick GN; Gonzalez DJ; Roberts AJ; Tanzi RE; Newton AC
Nat Commun; 2022 Nov; 13(1):7200. PubMed ID: 36418293
[TBL] [Abstract][Full Text] [Related]
4. Functional and Physical Interaction of Diacylglycerol Kinase ζ with Protein Kinase Cα Is Required for Cerebellar Long-Term Depression.
Lee D; Yamamoto Y; Kim E; Tanaka-Yamamoto K
J Neurosci; 2015 Nov; 35(46):15453-65. PubMed ID: 26586831
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.
Salazar SV; Cox TO; Lee S; Brody AH; Chyung AS; Haas LT; Strittmatter SM
J Neurosci; 2019 Jan; 39(4):758-772. PubMed ID: 30518596
[TBL] [Abstract][Full Text] [Related]
6. Science Signaling Podcast for 10 May 2016: PKCα in Alzheimer's disease.
Newton AC; Tanzi RE; VanHook AM
Sci Signal; 2016 May; 9(427):pc11. PubMed ID: 27165779
[TBL] [Abstract][Full Text] [Related]
7. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
Tackenberg C; Kulic L; Nitsch RM
PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
[TBL] [Abstract][Full Text] [Related]
8. PKC ε activation prevents synaptic loss, Aβ elevation, and cognitive deficits in Alzheimer's disease transgenic mice.
Hongpaisan J; Sun MK; Alkon DL
J Neurosci; 2011 Jan; 31(2):630-43. PubMed ID: 21228172
[TBL] [Abstract][Full Text] [Related]
9. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.
Jang YN; Jang H; Kim GH; Noh JE; Chang KA; Lee KJ
Neuropathol Appl Neurobiol; 2021 Aug; 47(5):625-639. PubMed ID: 33345400
[TBL] [Abstract][Full Text] [Related]
10. REDD1 Is Involved in Amyloid β-Induced Synaptic Dysfunction and Memory Impairment.
Yi JH; Kwon H; Cho E; Jeon J; Lee J; Lee YC; Cho JH; Jun M; Moon M; Ryu JH; Kim JS; Choi JW; Park SJ; Lee S; Kim DH
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322202
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase Cα promotes cell migration through a PDZ-dependent interaction with its novel substrate discs large homolog 1 (DLG1).
O'Neill AK; Gallegos LL; Justilien V; Garcia EL; Leitges M; Fields AP; Hall RA; Newton AC
J Biol Chem; 2011 Dec; 286(50):43559-68. PubMed ID: 22027822
[TBL] [Abstract][Full Text] [Related]
12. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons.
Calkins MJ; Reddy PH
Biochim Biophys Acta; 2011 Apr; 1812(4):507-13. PubMed ID: 21241801
[TBL] [Abstract][Full Text] [Related]
13. Regulation of amyloid precursor protein (APP) secretion by protein kinase calpha in human ntera 2 neurons (NT2N).
Jolly-Tornetta C; Wolf BA
Biochemistry; 2000 Jun; 39(25):7428-35. PubMed ID: 10858291
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
[TBL] [Abstract][Full Text] [Related]
15. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
[TBL] [Abstract][Full Text] [Related]
16. Enhanced generation of Alzheimer's amyloid-beta following chronic exposure to phorbol ester correlates with differential effects on alpha and epsilon isozymes of protein kinase C.
da Cruz e Silva OA; Rebelo S; Vieira SI; Gandy S; da Cruz e Silva EF; Greengard P
J Neurochem; 2009 Jan; 108(2):319-30. PubMed ID: 19012746
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis.
Hill KS; Erdogan E; Khoor A; Walsh MP; Leitges M; Murray NR; Fields AP
Oncogene; 2014 Apr; 33(16):2134-44. PubMed ID: 23604119
[TBL] [Abstract][Full Text] [Related]
18. NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.
Müller MK; Jacobi E; Sakimura K; Malinow R; von Engelhardt J
Acta Neuropathol Commun; 2018 Oct; 6(1):110. PubMed ID: 30352630
[TBL] [Abstract][Full Text] [Related]
19. The last 10 amino acid residues beyond the hydrophobic motif are critical for the catalytic competence and function of protein kinase Calpha.
Yeong SS; Zhu Y; Smith D; Verma C; Lim WG; Tan BJ; Li QT; Cheung NS; Cai M; Zhu YZ; Zhou SF; Tan SL; Duan W
J Biol Chem; 2006 Oct; 281(41):30768-81. PubMed ID: 16895917
[TBL] [Abstract][Full Text] [Related]
20. Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.
Izzo NJ; Yuede CM; LaBarbera KM; Limegrover CS; Rehak C; Yurko R; Waybright L; Look G; Rishton G; Safferstein H; Hamby ME; Williams C; Sadlek K; Edwards HM; Davis CS; Grundman M; Schneider LS; DeKosky ST; Chelsky D; Pike I; Henstridge C; Blennow K; Zetterberg H; LeVine H; Spires-Jones TL; Cirrito JR; Catalano SM
Alzheimers Dement; 2021 Aug; 17(8):1365-1382. PubMed ID: 33559354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
